CVS PCSU SJH, REF SJCV48J
During an internal investigation, ACS identified that the components, I.V. Cath (part number 4252535-02) and Adhesive Dermabond (part number DHVM12) were inadvertently subjected to the ACS sterilization process and exposed to EO and higher temperatures than approved by the component manufacturer. As a result, the components may (1) have a loss/lack of functionality, (2) loss of drug efficacy, if applicable, and (3) have higher than specified EO residuals.
US Nationwide distribution in the states of FL, IA.
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0175-2024